https://www.crcl.fr/publications/prmt5-triggers-glucocorticoid-induced-cell-migration-in-triple-negative-breast-cancer/ 2025-09-22T08:39:42+00:00 https://www.crcl.fr/publications/role-of-prmt1-and-prmt5-in-breast-cancer/ 2025-09-22T08:43:14+00:00 https://www.crcl.fr/publications/evidence-that-dmrta2-acts-through-repression-of-pax6-in-cortical-patterning-and-identification-of-a-mutation-impairing-dna-recognition-associated-with-microcephaly-in-human/ 2025-09-22T08:45:42+00:00 https://www.crcl.fr/publications/neuroprotective-effects-of-g9a-inhibition-through-modulation-of-peroxisome-proliferator-activator-receptor-gamma-dependent-pathways-by-mir-128/ 2025-09-22T08:49:05+00:00 https://www.crcl.fr/publications/g9a-inhibition-promotes-neuroprotection-through-gmfb-regulation-in-alzheimers-disease/ 2025-09-22T08:53:56+00:00 https://www.crcl.fr/publications/cytoskeleton-remodeling-induced-by-smyd2-methyltransferase-drives-breast-cancer-metastasis/ 2025-09-22T13:06:34+00:00 https://www.crcl.fr/publications/cancer-associated-fibroblasts-produce-netrin-1-to-control-cancer-cell-plasticity-2/ 2025-09-22T13:57:45+00:00 https://www.crcl.fr/publications/cancer-vaccines-whats-next/ 2025-09-22T14:02:16+00:00 https://www.crcl.fr/publications/cold-tumors-a-therapeutic-challenge-for-immunotherapy-2/ 2025-09-22T14:03:30+00:00 https://www.crcl.fr/publications/les-car-t-cells-en-hematologie/ 2025-09-24T08:05:42+00:00 https://www.crcl.fr/publications/immunogenomic-profiling-of-the-randomized-neopembrov-clinical-trial-2-reveals-regulatory-t-cells-and-the-vegfr2-angiogenic-axis-as-promising-3-actionable-targets-to-overcome-immunoresistance-of-high-g/ 2025-09-26T13:59:07+00:00 https://www.crcl.fr/publications/modulation-of-blood-t-cell-polyfunctionality-and-hvem-btla-expression-are-critical-determinants-of-clinical-outcome-in-anti-pd1-treated-metastatic-melanoma-patients-2/ 2025-09-26T14:03:57+00:00 https://www.crcl.fr/publications/isolation-and-identification-of-dendritic-cell-subsets-from-human-and-mouse-tumors/ 2025-09-29T07:27:35+00:00 https://www.crcl.fr/publications/tumor-associated-dendritic-cells-in-human/ 2025-09-29T07:28:49+00:00 https://www.crcl.fr/publications/guidelines-for-visualization-and-analysis-of-dc-in-tissues-using-multiparameter-fluorescence-microscopy-imaging-methods/ 2025-09-29T07:29:55+00:00 https://www.crcl.fr/publications/hervs-characterize-normal-and-leukemia-stem-cells-and-represent-a-source-of-epitopes-for-cancer-immunotherapy/ 2025-09-29T07:31:37+00:00 https://www.crcl.fr/publications/direct-t-cell-presentation-by-cdc1-the-key-feature-for-cancer-vaccine-success/ 2025-09-29T07:34:38+00:00 https://www.crcl.fr/publications/diversification-of-circulating-and-tumor-infiltrating-plasmacytoid-dcs-towards-the-p3-cd80-pdl1-pdc-subset-negatively-correlated-with-clinical-outcomes-in-melanoma-patients/ 2025-09-29T07:35:52+00:00 https://www.crcl.fr/publications/identification-of-shared-tumor-epitopes-from-endogenous-retroviruses-inducing-high-avidity-cytotoxic-t-cells-for-cancer-immunotherapy-2/ 2025-09-29T07:37:11+00:00 https://www.crcl.fr/publications/tumor-burden-and-antigen-specific-t-cell-magnitude-represent-major-parameters-for-clinical-response-to-cancer-vaccine-and-tcr-t-cell-therapy/ 2025-09-29T07:38:31+00:00 https://www.crcl.fr/publications/ifn-iii-is-selectively-produced-by-cdc1-and-predicts-good-clinical-outcome-in-breast-cancer-3/ 2025-09-29T07:39:32+00:00 https://www.crcl.fr/publications/ifn-iii-is-selectively-produced-by-cdc1-and-predicts-good-clinical-outcome-in-human-breast-cancer/ 2025-09-29T07:41:15+00:00 https://www.crcl.fr/publications/ifn-iii-is-selectively-produced-by-cdc1-and-predicts-good-clinical-outcome-in-breast-cancer/ 2025-09-29T07:41:18+00:00 https://www.crcl.fr/publications/expression-of-tam-r-in-human-immune-cells-and-unique-regulatory-function-of-mertk-in-il-10-production-by-tolerogenic-dc-2/ 2025-09-29T07:42:00+00:00 https://www.crcl.fr/publications/cancer-associated-fibroblasts-produce-netrin-1-to-control-cancer-cell-plasticity/ 2025-09-29T07:42:50+00:00 https://www.crcl.fr/publications/tcr-engineered-t-cell-therapy-in-solid-tumors-state-of-the-art-and-perspectives-2/ 2025-09-29T07:44:01+00:00 https://www.crcl.fr/publications/radiotherapy-as-a-means-to-increase-the-efficacy-of-t-cell-therapy-in-solid-tumors/ 2025-09-29T07:44:57+00:00 https://www.crcl.fr/publications/development-of-allogeneic-car-t-cells/ 2025-09-29T07:45:59+00:00 https://www.crcl.fr/publications/towards-off-the-shelf-allogeneic-car-t-cell/ 2025-09-29T07:47:23+00:00 https://www.crcl.fr/publications/off-the-shelf-allogeneic-car-t-cells-development-and-challenges/ 2025-09-29T07:48:48+00:00 https://www.crcl.fr/publications/t-cell-based-immunotherapies-in-solid-tumors/ 2025-09-29T07:50:22+00:00 https://www.crcl.fr/publications/cd4-t-lymphocytes-major-players-in-antitumor-immune-response/ 2025-09-29T07:51:46+00:00 https://www.crcl.fr/publications/neoepitopes-based-vaccines-challenges-and-perspectives/ 2025-09-29T07:54:04+00:00 https://www.crcl.fr/publications/neoepitopes-based-vaccines-challenges-and-perspectives-3/ 2025-09-29T07:54:36+00:00 https://www.crcl.fr/publications/pattern-recognition-receptors-immune-targets-to-enhance-cancer-immunotherapy/ 2025-09-29T07:55:30+00:00 https://www.crcl.fr/publications/a-phenotypic-journey-into-nt5dc-proteins-in-cancer-and-other-diseases/ 2025-09-30T13:59:07+00:00 https://www.crcl.fr/publications/the-synergy-between-alkylating-agents-and-ercc1-xpf-inhibitors-is-p53-dependent/ 2025-09-30T14:04:13+00:00 https://www.crcl.fr/publications/oxphos-inhibitors-metabolism-and-targeted-therapies-in-cancer/ 2025-09-30T14:08:08+00:00 https://www.crcl.fr/publications/a-systemically-administered-detoxified-tlr4-agonist-displays-potent-antitumor-activity-and-an-acceptable-tolerance-profile-in-preclinical-models/ 2025-09-30T14:10:26+00:00 https://www.crcl.fr/publications/payload-diversification-a-key-step-in-the-development-of-antibody-drug-conjugates/ 2025-09-30T14:13:40+00:00 https://www.crcl.fr/publications/impact-of-mouse-model-tumor-implantation-site-on-acquired-resistance-to-anti-pd-1-immune-checkpoint-therapy/ 2025-09-30T14:14:57+00:00 https://www.crcl.fr/publications/identification-of-a-mirna-multi-targeting-therapeutic-strategy-in-glioblastoma-2/ 2025-10-03T09:34:41+00:00 https://www.crcl.fr/publications/the-endoplasmic-reticulum-kinase-perk-interacts-with-the-oxidoreductase-ero1-to-metabolically-adapt-mitochondria/ 2025-10-03T09:43:20+00:00 https://www.crcl.fr/publications/diet-enriched-in-saturated-fatty-acids-induces-liver-oxidative-stress-and-elicits-inflammatory-pathways-prior-to-metabolic-disruption-in-perinatal-protein-undernutrition/ 2025-10-03T09:47:50+00:00 https://www.crcl.fr/publications/articular-cartilage-repair-after-implantation-of-hyaline-cartilage-beads-engineered-from-adult-dedifferentiated-chondrocytes-cartibeads-preclinical-efficacy-study-in-a-large-animal-model/ 2025-10-03T09:52:46+00:00 https://www.crcl.fr/publications/genomics-to-select-treatment-for-patients-with-metastatic-breast-cancer/ 2025-10-03T09:58:13+00:00 https://www.crcl.fr/publications/hyaline-cartilage-microtissues-engineered-from-adult-dedifferentiated-chondrocytes-safety-and-role-of-wnt-signaling/ 2025-10-03T10:04:21+00:00 https://www.crcl.fr/publications/bmp2-and-bmp7-cooperate-with-h3-3k27m-to-promote-quiescence-and-invasiveness-in-pediatric-diffuse-midline-gliomas-2/ 2025-10-03T10:11:03+00:00 https://www.crcl.fr/publications/expert-consensus-on-the-prevention-of-brain-metastases-in-patients-with-her2-positive-breast-cancer/ 2025-10-03T10:24:03+00:00 https://www.crcl.fr/publications/association-between-endocrine-adjuvant-therapy-intake-timing-and-disease-free-survival-in-patients-with-high-risk-early-breast-cancer-results-of-a-sub-study-of-the-ucbg-unirad-trial/ 2025-10-03T10:28:48+00:00 https://www.crcl.fr/publications/p4ebp1-staining-predicts-outcome-in-er-positive-endocrine-resistant-metastatic-breast-cancer-patients-treated-with-everolimus-and-exemestane/ 2025-10-03T10:33:00+00:00 https://www.crcl.fr/publications/overall-survival-with-circulating-tumor-cell-count-driven-choice-of-therapy-in-advanced-breast-cancer-a-randomized-trial/ 2025-10-03T10:36:23+00:00 https://www.crcl.fr/publications/insights-adjusting-for-non-adherence-in-randomized-clinical-trials-a-reanalysis-of-an-adjuvant-trial-of-tamoxifen-duration-in-early-breast-cancer/ 2025-10-03T10:40:52+00:00 https://www.crcl.fr/publications/real-world-impact-of-adjuvant-anti-her2-treatment-on-characteristics-and-outcomes-of-women-with-her2-positive-metastatic-breast-cancer-in-the-esme-program/ 2025-10-03T10:43:23+00:00 https://www.crcl.fr/publications/trastuzumab-deruxtecan-in-metastatic-breast-cancer-with-variable-her2-expression-the-phase-2-daisy-trial/ 2025-10-03T10:46:03+00:00 https://www.crcl.fr/publications/clinical-outcome-of-patients-with-isolated-central-nervous-system-progression-on-first-line-pertuzumab-and-trastuzumab-treatment-for-her2-positive-metastatic-breast-cancer-in-a-real-life-cohort/ 2025-10-03T10:48:27+00:00 https://www.crcl.fr/publications/progression-free-survival-on-endocrine-therapy-before-or-after-chemotherapy-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2025-10-03T10:51:45+00:00 https://www.crcl.fr/publications/impact-of-lobular-versus-ductal-histology-on-overall-survival-in-metastatic-breast-cancer-a-french-retrospective-multicentre-cohort-study/ 2025-10-03T10:56:17+00:00 https://www.crcl.fr/publications/everolimus-added-to-adjuvant-endocrine-therapy-in-patients-with-high-risk-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-primary-breast-cancer/ 2025-10-03T10:58:48+00:00 https://www.crcl.fr/publications/galectin-functions-in-cancer-associated-inflammation-and-thrombosis/ 2025-10-03T11:02:14+00:00 https://www.crcl.fr/publications/modelling-cancer-metabolism-in-vitro-current-improvements-and-future-challenges/ 2025-10-03T11:06:06+00:00 https://www.crcl.fr/publications/the-strategic-roles-of-four-enzymes-in-the-interconnection-between-metabolism-and-oncogene-activation-in-non-small-cell-lung-cancer-therapeutic-implications/ 2025-10-03T11:11:02+00:00 https://www.crcl.fr/publications/mast-cells-act-as-pro-angiogenic-and-pro-tumorigenic-players-in-pituitary-gonadotroph-tumors/ 2025-11-27T09:48:41+00:00 https://www.crcl.fr/publications/the-proinflammatory-secretome-of-senescent-cells-can-be-controlled-by-a-hif2a-dependent-upregulation-and-a-furin-dependent-cleavage-of-the-angptl4-secreted-factor/ 2025-12-16T15:24:35+00:00 https://www.crcl.fr/publications/abrogation-of-aberrant-glycolytic-interactions-eliminates-senescent-cells-and-alleviates-aging-related-dysfunctions/ 2025-12-16T15:28:17+00:00 https://www.crcl.fr/publications/mast-cells-act-as-pro-angiogenic-and-pro-tumorigenic-players-in-pituitary-gonadotroph-tumor/ 2025-12-16T15:32:29+00:00 https://www.crcl.fr/publications/notch3-regulates-mybl2-via-heyl-to-limit-proliferation-and-tumor-initiation-in-breast-cancer-2/ 2025-12-17T09:09:57+00:00 https://www.crcl.fr/publications/metastatic-infiltration-of-nervous-tissue-and-periosteal-nerve-sprouting-in-multiple-myeloma-induced-bone-pain-in-mice-and-human/ 2025-12-17T09:18:26+00:00 https://www.crcl.fr/publications/notch-receptor-ligand-diversity-contribution-to-colorectal-cancer-stem-cell-heterogeneity/ 2025-12-17T09:21:20+00:00 https://www.crcl.fr/publications/netrin-1-feedforward-mechanism-promotes-pancreatic-cancer-liver-metastasis-via-hepatic-stellate-cell-activation-retinoid-and-elf3-signaling/ 2025-12-17T09:21:42+00:00 https://www.crcl.fr/publications/anti-netrin-1-decorated-nanoparticles-combined-with-chemotherapy-for-the-treatment-of-triple-negative-breast-cancer/ 2025-12-17T09:24:06+00:00 https://www.crcl.fr/publications/netrin-signaling-mediates-survival-of-dormant-epithelial-ovarian-cancer-cells/ 2025-12-17T09:24:32+00:00 https://www.crcl.fr/publications/protocol-for-isolating-extracellular-vesicles-from-pancreatic-cancer-cells-for-liver-metastatic-niche-research/ 2025-12-17T09:25:51+00:00 https://www.crcl.fr/publications/netrin-1-and-unc5b-cooperate-with-integrins-to-mediate-yap-driven-cytostasis/ 2025-12-17T09:27:09+00:00 https://www.crcl.fr/publications/sonic-hedgehog-medulloblastomas-are-dependent-on-netrin-1-for-survival/ 2025-12-17T09:30:19+00:00 https://www.crcl.fr/publications/neural-function-of-netrin-1-in-precancerous-lesions-of-the-pancreas/ 2025-12-17T09:30:47+00:00 https://www.crcl.fr/publications/molecular-versatility-during-pluripotency-progression/ 2025-12-17T09:49:59+00:00 https://www.crcl.fr/publications/cellular-plasticity-in-reprogramming-rejuvenation-and-tumorigenesis-a-pioneer-tf-perspective/ 2025-12-17T09:56:13+00:00 https://www.crcl.fr/publications/comparative-roadmaps-of-reprogramming-and-oncogenic-transformation-identify-bcl11b-and-atoh8-as-broad-regulators-of-cellular-plasticity-2/ 2025-12-17T09:59:34+00:00 https://www.crcl.fr/publications/rsl24d1-sustains-steady-state-ribosome-biogenesis-and-pluripotency-translational-programs-in-embryonic-stem-cells-4/ 2025-12-17T12:37:16+00:00 https://www.crcl.fr/publications/reprogramming-stars-24-pluripotency-and-oncogenic-transformation-a-series-of-intermingling-events-an-interview-with-dr-fabrice-lavial/ 2025-12-17T12:39:34+00:00 https://www.crcl.fr/publications/deep-phenotyping-of-nodal-t-cell-lymphomas-reveals-immune-alterations-and-therapeutic-targets/ 2025-12-17T13:46:59+00:00 https://www.crcl.fr/publications/immunophenotyping-of-peripheral-blood-cells-in-patients-with-chronic-lymphocytic-leukemia-treated-with-ibrutinib/ 2025-12-17T13:48:46+00:00 https://www.crcl.fr/publications/nf-%ce%bab-subunits-rela-and-c-rel-selectively-control-cd4-t-cell-function-in-multiple-sclerosis-and-cancer/ 2025-12-17T13:49:55+00:00 https://www.crcl.fr/app/uploads/2024/04/JEM400x400-e1714381535826.png https://www.crcl.fr/publications/fibrillarin-mediated-ribosomal-rna-maturation-is-a-novel-therapeutic-vulnerability-in-triple-negative-breast-cancer/ 2025-12-19T10:19:42+00:00 https://www.crcl.fr/publications/patterns-of-care-and-outcome-of-cic-rearranged-sarcoma-patients-a-nationwide-study-of-the-french-sarcoma-group/ 2025-12-19T10:54:36+00:00 https://www.crcl.fr/publications/esr1-rearrangement-as-a-diagnostic-and-predictive-biomarker-in-uterine-tumor-resembling-ovarian-sex-cord-tumor-a-report-of-four-cases/ 2025-12-19T11:00:50+00:00 https://www.crcl.fr/publications/clinical-characteristics-and-outcomes-for-children-adolescents-and-young-adults-with-cic-fused-or-bcor-rearranged-soft-tissue-sarcomas-a-multi-institutional-european-retrospective-analysis/ 2025-12-19T11:08:03+00:00 https://www.crcl.fr/publications/natural-history-and-treatment-efficacy-in-an-ambispective-case-series-of-ntrk-rearranged-mesenchymal-tumors/ 2025-12-19T11:10:58+00:00 https://www.crcl.fr/publications/targeted-long-read-sequencing-of-the-ewing-sarcoma-6p25-1-susceptibility-locus-identifies-germline-somatic-interactions-with-ewsr1-fli1-binding/ 2025-12-19T11:15:30+00:00 https://www.crcl.fr/publications/translational-aspects-of-epithelioid-sarcoma-current-consensus/ 2025-12-19T11:18:36+00:00 https://www.crcl.fr/publications/brief-communication-on-mage-a4-and-coexpression-of-cancer-testis-antigens-in-metastatic-synovial-sarcomas-considerations-for-development-of-immunotherapeutics/ 2025-12-19T11:22:55+00:00 https://www.crcl.fr/publications/high-expression-level-of-erbb2-and-efficacy-of-trastuzumab-deruxtecan-in-desmoplastic-small-round-cell-tumour-a-monocentric-case-series-report/ 2025-12-19T12:45:08+00:00 https://www.crcl.fr/publications/yap1kmt2a-rearranged-sarcoma-report-of-a-new-case-with-unusual-morphology-and-immunohistochemical-features/ 2025-12-19T12:49:48+00:00 https://www.crcl.fr/publications/assessing-targetable-ntrk1-2-3-fusions-in-mesenchymal-tumors-via-whole-exome-rna-sequencing/ 2025-12-19T12:55:19+00:00 https://www.crcl.fr/publications/multi-omics-profiling-identified-two-epithelioid-sarcoma-molecular-subtypes-with-distinct-signaling-and-immune-characteristics/ 2025-12-19T13:03:40+00:00 https://www.crcl.fr/publications/bone-tumour-with-crtc1trim11-gene-rearrangement/ 2025-12-19T13:09:45+00:00 https://www.crcl.fr/publications/comprehensive-molecular-portrait-reveals-genetic-diversity-and-distinct-molecular-subtypes-of-small-intestinal-neuroendocrine-tumors/ 2025-12-19T15:16:39+00:00 https://www.crcl.fr/publications/oxaliplatin-based-versus-alkylating-agent-in-neuroendocrine-tumors-according-to-the-o6-methylguanine-dna-methyltransferase-status-a-randomized-phase-ii-study-mgmt-net/ 2025-12-19T15:25:44+00:00 https://www.crcl.fr/publications/uncovering-immune-checkpoint-heterogeneity-in-oral-squamous-cell-carcinoma-using-single-cell-rna-sequencing-data-highlights-three-subgroups-of-patients-with-distinct-immune-phenotypes/ 2025-12-22T12:48:21+00:00 https://www.crcl.fr/publications/pd-1-blockade-in-solid-tumors-with-defects-in-polymerase-epsilon/ 2025-12-22T12:52:39+00:00 https://www.crcl.fr/publications/immunologically-active-phenotype-by-gene-expression-profiling-is-associated-with-clinical-benefit-from-pd-1-pd-l1-inhibitors-in-real-world-head-and-neck-and-lung-cancer-patients-2/ 2025-12-22T13:05:58+00:00 https://www.crcl.fr/publications/clinical-relevance-of-an-amplicon-based-liquid-biopsy-for-detecting-alk-and-ros1-fusion-and-resistance-mutations-in-patients-with-non-small-cell-lung-cancer-2/ 2025-12-22T13:07:12+00:00 https://www.crcl.fr/publications/immunological-and-classical-subtypes-of-oral-premalignant-lesions-3/ 2025-12-22T13:08:57+00:00 https://www.crcl.fr/publications/met-receptor-tyrosine-kinase-and-chemoprevention-of-oral-cancer-2/ 2025-12-22T13:10:21+00:00 https://www.crcl.fr/publications/the-immune-microenvironment-of-hpv-negative-oral-squamous-cell-carcinoma-from-never-smokers-and-never-drinkers-patients-suggests-higher-clinical-benefit-of-ido1-and-pd1-pd-l1-blockade-6/ 2025-12-22T13:11:47+00:00 https://www.crcl.fr/publications/comprehensive-biomarker-analysis-and-final-efficacy-results-of-sorafenib-in-the-battle-trial/ 2025-12-22T13:12:54+00:00 https://www.crcl.fr/publications/deltanp63-overexpression-alone-and-in-combination-with-other-biomarkers-predicts-the-development-of-oral-cancer-in-patients-with-leukoplakia/ 2025-12-22T13:14:09+00:00 https://www.crcl.fr/publications/gene-expression-profiling-predicts-the-development-of-oral-cancer/ 2025-12-22T13:15:16+00:00 https://www.crcl.fr/publications/translon-a-single-term-for-translated-regions/ 2026-01-07T07:29:09+00:00 https://www.crcl.fr/publications/exploring-and-bypassing-resistance-to-targeted-therapies-in-colorectal-cancer/ 2026-01-07T17:17:12+00:00 https://www.crcl.fr/publications/beyond-rodents-alternative-animal-models-in-colorectal-cancer-research/ 2026-01-07T17:20:27+00:00 https://www.crcl.fr/publications/fibrillarin-contributes-to-the-oncogenic-characteristics-of-colorectal-cancer-cells-and-reduces-sensitivity-to-5-fluorouracil/ 2026-01-07T17:23:35+00:00 https://www.crcl.fr/publications/specific-modulation-of-28s_um2402-rrna-2%e2%80%b2-o-ribose-methylation-as-a-novel-epitranscriptomic-marker-of-zeb1-induced-epithelial-mesenchymal-transition-in-different-mammary-cell-contexts/ 2026-01-07T17:27:24+00:00 https://www.crcl.fr/publications/ribosome-biogenesis-is-a-therapeutic-vulnerability-in-pediatric-neuroblastoma/ 2026-01-07T17:32:59+00:00 https://www.crcl.fr/publications/isocitrate-dehydrogenase-wt-and-idhmut-adult-type-diffuse-gliomas-display-distinct-alterations-in-ribosome-biogenesis-and-2o-methylation-of-ribosomal-rna-2/ 2026-01-07T17:33:26+00:00 https://www.crcl.fr/publications/low-level-of-fibrillarin-a-ribosome-biogenesis-factor-is-a-new-independent-marker-of-poor-outcome-in-breast-cancer/ 2026-01-07T17:39:40+00:00 https://www.crcl.fr/publications/ribosomal-rna-2%e2%80%b2o-methylation-as-a-novel-layer-of-inter-tumour-heterogeneity-in-breast-cancer/ 2026-01-07T17:42:36+00:00 https://www.crcl.fr/publications/study-of-intracellular-anabolism-of-5-fluorouracil-and-incorporation-in-nucleic-acids-based-on-an-lc-hrms-method/ 2026-01-07T17:46:33+00:00 https://www.crcl.fr/publications/customization-of-the-translational-complexcustomization-of-the-translational-complex-regulates-mrna-specific-translation-to-control-cns-regenerationcustomization-of-the-translational-complex/ 2026-01-07T17:51:00+00:00 https://www.crcl.fr/publications/ribosome-biogenesis-an-emerging-druggable-pathway-for-cancer-therapeutics/ 2026-01-07T18:06:19+00:00 https://www.crcl.fr/publications/2%e2%80%b2-o-methylation-of-ribosomal-rna-towards-an-epitranscriptomic-control-of-translation/ 2026-01-07T18:08:43+00:00 https://www.crcl.fr/publications/the-goldilocks-paradox-when-partial-oncoprotein-inhibition-fuels-metastasis-in-ewing-sarcoma/ 2026-01-08T11:52:05+00:00 https://www.crcl.fr/publications/atypical-contribution-of-caspase-3-to-melanoma-cancer-cell-motility-by-regulation-of-coronin-1b-activity/ 2026-01-16T17:11:20+00:00 https://www.crcl.fr/publications/in-silico-and-in-vitro-characterization-of-gh12-an-innovative-peptide-for-dental-pulp-regeneration/ 2026-01-16T17:18:16+00:00 https://www.crcl.fr/publications/harnessing-the-power-of-an-advanced-in-vitro-3d-liver-model-and-error-corrected-duplex-sequencing-for-the-detection-of-mutational-signatures/ 2026-01-16T17:22:37+00:00 https://www.crcl.fr/publications/interleukin-35-impairs-human-nk-cell-effector-functions-and-induces-their-ilc1-like-conversion-with-tissue-residency-features/ 2026-01-23T15:46:57+00:00 https://www.crcl.fr/publications/integralign-a-comprehensive-tool-for-multi-immunofluorescence-panel-integration-through-image-alignment-2/ 2026-01-26T08:37:13+00:00 https://www.crcl.fr/publications/high-expression-of-ccl2-correlated-with-dendritic-cell-recruitment-in-neuroblastomas-associated-with-opsoclonus-myoclonus-syndrome/ 2026-01-26T08:39:44+00:00 https://www.crcl.fr/publications/type-iii-interferon-primes-pdcs-for-tlr7-activation-and-antagonizes-immune-suppression-mediated-by-tgf-b-and-pge2/ 2026-01-26T11:09:22+00:00 https://www.crcl.fr/publications/the-spatial-organization-of-cdc1-with-cd8-t-cells-is-critical-for-the-response-to-immune-checkpoint-inhibitors-in-melanoma-patients/ 2026-01-26T11:17:32+00:00 https://www.crcl.fr/publications/immunogenomic-profiling-of-the-randomized-neopembrov-clinical-trial-2-reveals-regulatory-t-cells-and-the-vegfr2-angiogenic-axis-as-promising-3-actionable-targets-to-overcome-immunoresistance-of-high-2/ 2026-01-26T11:18:14+00:00 https://www.crcl.fr/publications/modulation-of-blood-t-cell-polyfunctionality-and-hvem-btla-expression-are-critical-determinants-of-clinical-outcome-in-anti-pd1-treated-metastatic-melanoma-patients-3/ 2026-01-26T11:20:00+00:00 https://www.crcl.fr/publications/the-csf-1r-inhibitor-pexidartinib-affects-flt3-dependent-dc-differentiation-and-may-antagonize-durvalumab-in-patients-with-advanced-cancers/ 2026-01-26T11:22:05+00:00 https://www.crcl.fr/publications/dendritic-cells-the-central-partner-for-cancer-immunity/ 2026-01-26T16:06:23+00:00 https://www.crcl.fr/publications/heterogeneity-and-functions-of-tumor-infiltrating-antibody-secreting-cells-lessons-from-breast-ovarian-and-other-solid-cancers/ 2026-01-26T16:10:28+00:00 https://www.crcl.fr/publications/direct-t-cell-presentation-by-cdc1-the-key-feature-for-cancer-vaccine-success-2/ 2026-01-26T16:12:44+00:00 https://www.crcl.fr/publications/isolation-and-identification-of-dendritic-cell-subsets-from-human-and-mouse-tumors-2/ 2026-01-26T16:17:01+00:00 https://www.crcl.fr/publications/phenotypes-and-functions-of-human-dendritic-cell-subsets-in-the-tumor-microenvironment/ 2026-01-26T16:19:19+00:00 https://www.crcl.fr/publications/interleukin-35-impairs-human-nk-cell-effector-functions-and-induces-their-ilc1-like-conversion-with-tissue-residency-features-2/ 2026-02-03T10:32:52+00:00 https://www.crcl.fr/publications/neoadjuvant-immune-checkpoint-blockade-before-chemoradiation-for-cervical-squamous-carcinoma-gineco-window-of-opportunity-colibri-study-a-phase-ii-trial/ 2026-02-03T10:51:28+00:00 https://www.crcl.fr/publications/pyroptotic-cell-death-the-role-of-membrane-permeability-in-swelling-and-lysis/ 2026-03-24T08:03:48+00:00 https://www.crcl.fr/publications/tumor-metabolic-adaptation-induced-by-l-asparaginase-reveals-a-vulnerability-to-parp1-2-inhibitor-in-b-cell-lymphomas/ 2026-03-24T08:06:48+00:00 https://www.crcl.fr/publications/aging-catalyst-or-barrier-cancer/ 2026-06-25T12:33:44+00:00 https://www.crcl.fr/publications/cell-senescence-biological-complexity/ 2026-06-25T12:46:39+00:00 https://www.crcl.fr/publications/mast-cells-pituitary-gonadotroph-tumors/ 2026-06-25T12:54:16+00:00 https://www.crcl.fr/publications/senolytics-lung-inflammation/ 2026-06-25T13:02:34+00:00 https://www.crcl.fr/publications/prolyl-3-hydroxylase-2-supports-a-pro-angiogenic-milieu-promoting-colorectal-cancer-progression-and-metastasis/ 2026-07-15T12:46:14+00:00 https://www.crcl.fr/publications/kremen1-dependence-receptor-induces-sec24c-and-atg9a-dependent-cell-death/ 2026-07-15T12:49:13+00:00 https://www.crcl.fr/publications/netrin1-blockade-alleviates-resistance-to-chemotherapy-in-pancreatic-cancer/ 2026-07-15T12:51:30+00:00 https://www.crcl.fr/publications/humanized-avian-embryo-models-replicate-an-immune-tumor-environment-for-rapid-immunotherapy-studies/ 2026-07-16T19:33:54+00:00 https://www.crcl.fr/publications/ero1a-fosters-glioblastoma-aggressiveness-and-metabolic-flexibility-by-regulating-mitochondria-associated-membrane-dynamics/ 2026-07-17T13:10:29+00:00 https://www.crcl.fr/publications/neuroendocrine-tumours-through-an-epigenetic-lens-emerging-insights-for-diagnosis-and-treatment/ 2026-09-10T12:47:09+00:00 https://www.crcl.fr/publications/177lulu-edotreotide-versus-everolimus-for-gastroenteropancreatic-neuroendocrine-tumours-compete-a-phase-3-multicentre-randomised-open-label-superiority-trial/ 2026-09-10T12:52:51+00:00 https://www.crcl.fr/publications/long-read-sequencing-identifies-aberrant-fragmentation-patterns-linked-to-elevated-cell-free-dna-levels-in-cancer/ 2026-09-10T12:57:39+00:00 https://www.crcl.fr/publications/european-society-of-neuroendocrine-tumors-enets-2025-guidance-paper-for-lung-and-thymic-carcinoids/ 2026-09-10T13:00:52+00:00 https://www.crcl.fr/publications/neuroendocrine-tumors-and-pregnancy-the-french-pregnet-study/ 2026-09-10T13:04:13+00:00 https://www.crcl.fr/publications/deep-molecular-profiling-of-lung-neuroendocrine-tumours-and-supra-carcinoids/ 2026-09-10T13:18:10+00:00